Item 2. Unregistered Sales of Equity Securities
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table sets forth information with respect to purchases of shares of the Company’s common stock made during the quarter ended May 1, 2020 by or on behalf of the Company or any “affiliated purchaser,” as defined by Rule 10b-18(a)(3) of the Exchange Act:
Period
Total Number
of Shares
Purchased
Average Price
Paid Per
Share (1)
Total Number of
Shares
Purchased as
Part of Publicly
Announced
Plans or
Programs
Maximum Number of
Shares (or Approximate
Dollar Value) that May
Yet Be Purchased
Under the Plans or
Programs
2/1/2- – 2/28/20
102,003
$
147.08
102,003
Indeterminate (2)
2/29/20 – 3/27/20
147,646
$
135.49
147,646
Indeterminate (2)
3/28/20 – 5/1/20
—
$
—
—
Indeterminate (2)
Total for the quarter
249,649
$
140.23
249,649
Indeterminate (2)
(1)
Average price paid per share is calculated on a settlement basis and includes commissions and fees.
(2)
On June 3, 2019, the Company’s Board of Directors approved the repurchase of up to $50,000 of the Company’s common stock, with such authorization to expire on June 2, 2020. On March 7, 2020, the Company’s Board of Directors approved the repurchase of up to an additional $25,000 of the Company’s common stock, with such authorization to expire on March 5, 2021 to the extent it remains unused. This authorization was effective immediately and replaced the $50,000 share repurchase authorization which had been expended earlier in the third quarter of 2020. In response to the COVID-19 pandemic, however, the Company has temporarily suspended all future share repurchases.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.